” Dr. Abhishek Mahajan M.D., Fellowship In Cancer Imaging, MRes (KCL, London), FRCR (UK) Locum Consultant Radiologist The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool Honorary Senior Lecturer, University of Liverpool Staff Governor, CCC Associate Editor for Frontiers in Oncology, Frontiers in Nuclear Medicine and Frontiers in Radiology Professor of Radiology (NMC, India) Ex Consultant Radiologist (Tata Memorial Centre, Mumbai, India) “

 A certified Medical Oncologist from India’s Top Oncology/ Cancer training/ institute Tata Memorial Hospital, Mumbai with 5 years of experience in Clinical oncology and Heamatoncology (including BMT experience at ACTREC, KHARGHAR, NAVI MUMBAI). Assistant Professor and consultant in Medical Oncology (Aug 2021 till now) Tata Memorial Hospital, Parel, Mumbai, India

” Dr. Alfredo Addeo is an senior oncologist at the Geneva University Hospital, Geneva Switzerland. He completed his training and received a MD in oncology at the University school of medicine of Turin (Italy). Dr. Addeo has been working on Thoracic malignancies since 2006 and he is the lead thoracic oncologist at University Hospital of Geneva. Authors of several publications on international peer-reviewed journal”

 As a principal investigator at the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, in Mumbai, Dr. Amit Dutt leads a team of researchers who are working to develop new treatments for cancer based on the genomic characteristics of individual tumors. Before joining ACTREC, Dr. Dutt completed his postdoctoral studies at the Broad Institute of MIT and Harvard, with a Ph.D in Developmental Biology from the University of Zurich. He is particularly interested in lung cancer, breast, head and neck cancer. He is also inetersted in developing novel computational approaches to analyze high throughput cancer genome dataset; and, study the pathogens associated with human cancer. Dr. has published numerous research articles in leading scientific journals and has received several awards and honors for his contributions to cancer research.

Dr Aneez D.B Ahmed is currently the Director & Senior Consultant Surgeon at International Centre for Thoracic Surgery in Mount Elizabeth Novena Specialist Centre, Singapore. He has been a practitioner in the field of thoracic surgery, with a special interest in thoracic oncology, for more than fifteen years. After completion of his cardiothoracic training from National University Hospital, Singapore, he passed his Fellowship exams from the Royal College of Surgeons of Edinburgh. Prior to starting his private practice, Dr Aneez served as the Head of Service of Thoracic Surgery in the Department of General Surgery in Tan Tock Seng Hospital (TTSH), Singapore. His interest in robotic surgery led him to be recognised as the first in the ASEAN cohort to get a Level III Certificate Specialist training in Robotic Thoracic Surgery from the European College of Cardiothoracic Surgery (EACTS). With sabbaticals in Europe and USA for advanced training in Robotic Thoracic surgery, he now leads the training program for thoracic surgeons in ASEAN and South Asia. He then became the Vice President of Robotic Surgical Society of Singapore (RS3) in 2016 and subsequently being nominated as the President of RS3 in 2019. His special interest in chest wall surgery led him to be a pioneer in Chest Wall Resection and Reconstruction. Dr Aneez had also performed the world’s first 3D Printed Polymer Ribcage Reconstruction. Dr Aneez is a member of various thoracic surgical groups internationally. He is also the Thoracic domain board member at the Asian Society of Cardiothoracic Surgery (ASCVTS), and he is the current General Secretary of the South East Asian Society of Thoracic Surgery (SEATS). His expertise and knowledge in minimally invasive thoracic surgery have led to numerous invitations as a speaker to conferences and workshops in the region. He also receives referrals from other hospitals in the country and other regions such as Malaysia, Thailand, Philippines and the U.A.E. Besides clinical works, Dr Aneez is passionate about teaching. Since 2010, Dr Aneez piloted a program in Advanced Thoracic Nursing Course (ATNC) at TTSH that has been running annually to train nurses from all over Asia. He is also an examiner for the Royal College of Surgeons of Edinburgh.

” Dr. Anne is asscoiate professor in GSL Medical college and Hospital, India. He is also the member of several medical oncology society as follows: ASCO; American Society of Clinical oncology, ESMO; European Society of Medical Oncology, AROI; Association of Radiation oncologists of India MSTS; Musculoskeletal tumour society “

Anu R I is a Cancer Multiomics specialist and Chemical Pathologist specialized in Cancer Biology, targeted therapy and translational research. Her primary interest lies in investigating molecular alterations in solid tumors on a multi-omic level. Her research also extends to cancer signalling pathway network analysis, and space biology using data mining and bioinformatics. She has two PG’s from Harvard Medical School to her credit, in High Impact Cancer Research (CBT-HICR) and Clinical Research Training. Anu R I currently works as Specialist in Precision Oncology and Multi-omics, and Head of Clinical Biochemistry in MVR CCRI, India. She is a member of three Analysis Working Groups- Multi-omics & Systems Biology, ALSDA, and AI for Space by NASA. She pursued MD in Clinical Biochemistry from Safdarjung hospital, New Delhi, and topped it with a Gold Medal. She has received numerous awards and accolades for experimental research on human genetics. She has delivered lectures on Precision Oncology on various platforms. Her vision encompasses strengthening Precision Oncology in the country and supporting cost-effective diagnostics for all patients with cancer.

Dr Anuj Kumar is an Assistant Professor in the Head and Neck Disease Management Group at Tata Memorial Centre, Mumbai. He has a keen interest in nasopharyngeal cancers, skull base tumours, reirradiation and advanced technologies like proton beam therapy. He gained hands-on experience with techniques like DNA Extraction, Polymerase Chain Reaction, and Restriction Fragment Length Polymorphisms from my time in a Cancer Genetics facility. He has also worked on projects in radiomics and knowledge-based planning. Dr Anuj intends to work on collaborative projects, shortened radiotherapy fractionation regimens and cost-effective treatment strategies, thereby expanding access to cancer care in this part of the world.

Dr. Chehal served as head of Hematology Oncology division at Sheikh Shakhbout Medical City from December 2019 until August 2020. Dr. Chehal main interests are Lung, Breast, Gyne, GI and GU malignancies.

Dr. Arman Reza Chowdhury is a Consultant Radiation Oncologist and Practicing Clinical Oncologist in Evercare Hospital Dhaka, Bangladesh – the first JCI accredited hospital in the country. He completed his fellowship in Oncology in 2014 followed by gained experiences from different oncology centres at home and abroad. He received UICC fellowship in 2014 and trained from TATA Memorial Hospital, Mumbai. He also trained from Guy’s Cancer Centre, London, United Kingdom on precision radiation oncology. He has a number of publications to his credit in reputed national and international journals. He is member of many national and international oncology societies and has delivered talks in several oncology conferences and workshops.

Dr. Arun is a medical oncologist in Prime Hospital. He Started in developing the Oncology Department at PRIME.

Dr. B. K. Mishra Deputy Director and Consultant, Medical Oncology HBCH & MPMMCC, Tata Memorial Centre, Varanasi Professional Journey: • MBBS: MLN Medical College, Prayagraj • MD: GSVM Medical College, Kanpur • DNB: National board of examinations, New Delhi • Medical Oncology training: Tata Memorial Hospital, Mumbai Area of interest: • Head Neck Cancer Number of publications: • 25

 Dr Bhuvan Chugh is a Medical Oncologist with rich experience in the treatment of solid organ cancers. He has a special interest in breast, thoracic, head & neck and hepato-billiary malignancies. He is the convener for the molecular tumour board at Max Saket and Gurgaon and has a keen interest in precision medicine. He has been an active part of the faculty both in terms of clinical and research work. Have co-authored many chapters, papers & abstracts in various national and international journals and conferences.

Dr. Birender Yadav is the Medical Director of Purbanchal Cancer Hospital.

” Dr Chirantan Bose (MBBS, MD, IFCAP, MBA, Post Doc Clinical Genetics ) works as Chief Molecular Pathologist and Laboratory Director – OneCell Diagnostics. Dr Bose currently leads clinical molecular oncology at OneCell and is PI to several ongoing research projects on Single cell genomics and liquid biopsy based cancer monitoring. He has almost two decades of leadership experience in Oncology Diagnostics and has global recognition in areas of cancer genetics, liquid biopsies, population based cancer screening and precision oncology research. He bridges the gap between the oncology lab and cancer patient care, coordinating crucially impactful molecular tumor boards for a diverse range of clinical practices across the world. Having received his clinical trainings from Gandhi Medical College Bhopal, Karolinska Institute, Sweden, University of Pittsburgh Medical Centre , USA and Univ of South Wales, he also received the best management student award from Washington University and IIT-BOMBAY. Dr Bose is also senior auditor with NABL/ISO 15189, NABH and a member of College of American Pathologists, with over 50 eminent publications in high impact journals.”

“Christine M. Lovly, MD, PhD is currently an Associate Professor of Medicine with tenure at the Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center. She received a B.A. in chemistry from Johns Hopkins University followed by M.D. and Ph.D. degrees as part of the Medical Scientist Training Program at Washington University in St. Louis, MO. She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her final year of fellowship, she was the Jim and Carol O’Hare Chief Fellow. She started on faculty at Vanderbilt in July 2013 as a physician scientist, splitting her time between clinical care and laboratory research. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer. Dr. Lovly has received grant funding from NIH/NCI, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the American Cancer Society, the Damon Runyon foundation, the LUNGevity foundation, the V Foundation, the American Association for Cancer Research, and Lung Cancer Foundation of America / International Association for the Study of Lung Cancer. She is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR). Dr. Lovly is also an elected member of the American Society for Clinical Investigation (ASCI) and a member of the Editorial Board for Cancer Discovery and JCO Precision Oncology. She serves on the Scientific Leadership Boards for the GO2 Foundation for Lung Cancer Research (where she also serves as SLB director), the LUNGevity Foundation, and the Lung Cancer Research Foundation. Dr. Lovly is a member of the AACR Science Policy and Government Affairs committee, co-chair of the Tobacco Products and Cancer subcommittee, and an elected member of the AACR Board of Directors. She serves on the NCCN guidelines panel for Non-Small Cell Lung Cancer and is co-chair of the ECOG-ACRIN Lung Biology Committee. In 2021, Dr. Lovly was awarded the ECOG-ACRIN Young Investigator Award. In 2022, she received the GO2 Foundation Asclepios Award honoring research pioneers in the fight to end lung cancer. “

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; Lung cancer, GI malignancies, and breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dinesh Chinchure is currently working as a Senior Consultant at Khoo Teck Puat Hospital. He had completed his MBBS from Gulbarga and FRCR from the United Kingdom. He is Specialized in Diagnostic Radiology.

” Prof. Dr. Md. Ehtashamul Hoque specialized in all types of Oncological treatment. Such as-Chemotherapy, Radiotherapy, Immunotherapy & Palliative Cancer Care. Prof. Dr. Md. Ehtashamul Hoque completed his MBBS from Chittagong Medical College in 1988. Then he completed his M. Phil (Radiotherapy) degree from Bangabandhu Sheikh Mujib Medical University (Ex. IPGMR) in 1999. Prof. Dr. Md. Ehtashamul Hoque started his carrier as a Medical officer at Kawokhali Upazila Health Complex, Rangamati in 1991. After a longer period of working in different areas of Bangladesh, he joined Resident Surgeon in the Radiotherapy unit at Dhaka Medical College. After that, he became Assistant Professor Radiation Oncology Department, NICRH in 2007. Thereafter he joined Anwar Khan Modern Medical College Hospital & became Head of the Department, Oncology. Then he Became Director, Admin Anwar Khan Modern Medical College Hospital in 2017. Besides this, he worked in Ahsania Mission Cancer Hospital & United Hospital Limited as a Consultant. Now he works at Labaid Cancer Hospital & Super Speciality Center as Senior Consultant, Radiation Oncology & Oncology from 2021. Last two decades he developed skilled manpower like doctors, nurses, and technicians. Through his teaching profession, he developed extraordinary Oncologists & Doctors throughout Bangladesh. He gives lectures on oncology in different areas of Bangladesh to train general practitioners and oncologists so that cancer care can be reached to every cancer patient of Bangladesh. He attends many national & international conferences, Seminars & Workshops as a Speaker. He also does public awareness programs on “prevention and treatment of cancer” in different parts of Bangladesh with general people and attends different Health & Cancer related talk shows as a TV & Media Person. Prof. Dr. Md. Ehtashamul Hoque affiliated with different National & International Societies. Such as-Bangladesh Medical Association (BMA), Bangladesh Society of Radiation Oncology (BSRO), Bangladesh Cancer Society (BCS), National Cancer Center (Singapore), Canadian Association of Radiation Oncology (CARO), American Society of Radiation Oncology (Astro), American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (EMSO), European Society of Therapeutic Radiology (ESTRO), American Association for Cancer Research (AACR), International Association for Study of Lung Cancer (IASLC), European Association for Cancer Research (EACR) Prof. Dr. Md. Ehtashamul Hoque published many kinds of research works in national & international journals. Also, he participated in a different training sessions in his 30 years longest successful & glorious career.”

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Professor El Karak is a Medical Doctor specialized in Hematology and Medical Oncology from Saint-Joseph University of Beirut from which he holds a Masters in Science. He is also a holder of a Masters in Clinical Development of Products of Health from France, Masters in Molecular Oncology from Spain and Executive Masters in Healthcare Management from ESA Business School. Pr. El Karak has performed a fellowship at Léon BERARD Cancer Center in Lyon-FRANCE and at Massachusetts General Hospital, Harvard Medical School in Boston- USA. He has authored and co-authored over 100 publications in leading international journals.

Dr. Hassan Shahryar is a consultant in medical oncology and hematology at the Sheikh Shakbout Medical City (SSMC) in partnership with Mayo Clinic and an adjunct clinical Associate Professor of Medicine at the Khalifa University in Abu Dhabi, UAE. He is Diplomate American Board of Internal Medicine, Geriatrics, Medical Oncology and Haematology. Dr. Shahryar practices general oncology in a large tertiary care public health system with a special interest in breast tumors. Dr. Shahryar is well published in peer reviewed international journals and is an invited speaker at the national and regional cancer conferences. He is a participant of the ESMO Leaders Generation Programme Asia 2022 and an active member of the ESMO Leadership Development Committee.

Dr. Justin F Gainor is the Director of the Center for Thoracic Cancers at Massachusetts General Hospital (MGH), also the Director of Targeted Immunotherapy in the Henri and Belinda Termeer Center for Targeted Therapies, and a Co-Leader of the SU2C Lung Cancer Dream Team. Their primary research interests revolve around two main themes: targeted therapy and immunotherapy. Presently, they serve as the principal investigator for several clinical trials assessing innovative targeted therapies in patients with oncogene-driven lung cancers, particularly focusing on oncogenic fusions involving anaplastic lymphoma kinase (ALK) and RET. Alongside these endeavors, they have also spearheaded initiatives to define the molecular mechanisms that lead to resistance to targeted therapies. In more recent times, Justin F Gainor has been dedicated to applying the same clinical-translational research framework utilized in targeted therapies to the realm of immunotherapy. Initial efforts in this area have been directed towards investigating the effectiveness of immune checkpoint inhibitors in patients with oncogene-driven lung cancers. Their ongoing research emphasis is on identifying factors that can predict responses to and resistance against immune checkpoint inhibitors. These translational studies are complemented by an extensive array of phase I/II trials that investigate innovative combinations of immunotherapies.

Dr. Das is a senior specialist oncologist in Dubai academic and health corporation (formerly DHA) since more than a decade. He has done his internal medicine fellowship in 2008 and medical Oncology fellowship in 2011. He continued his clinical and academic excellence and achieved membership of American college of physicians and royal college of physicians and surgeons Glasgow, UK mad succeed to get specialty certification in medical oncology from Royal college of physician UK. He has worked on different positions in Pakistan, Qatar and in UAE. He has been participating as faculty member in EIOC (formerly UAE-CC) since 09 consecutive years.

Dr. A.F.M Kamal Uddin completed his MBBS degree in 1990 and completed a Diploma in Chest Disease and Tuberculosis (DTCD) in 1996. In the year 2008, he became the first MD in Radiation Oncology in the country. He worked at the National Institute of Cancer Research and Hospital, the only tertiary-level cancer centre in the country from 1993 to 2010. Then went to attend a six-month IAEA fellowship at the University Pittsburgh Cancer Centre (UPMC), Pennsylvania, the USA in the Department of Radiation Oncology. He was also awarded the ICRETT fellowship of UICC in 2009 and worked at National Cancer Centre, Singapore as Fellow. He is now working as an Associate Professor (CC), Department of Radiation Oncology, National Institute of ENT (NIENT), Tejgaon, Dhaka. He is also acting as Visiting Consultant of Radiation Oncology, United Hospital, Senior Consultant at Labaid Cancer Hospital & Super Speciality Centre & Labaid Specialized Hospital. He is also acting as Honorary Consultant of Radiation Oncology, Bangladesh Atomic Energy Commission (BAEC). He also worked as Honorary Adviser for the Cancer Centre at Dhaka Cantonment “Oncology Centre”. He was elected the Secretary-General of SAARC Federation Oncologists (SFO) twice and now he is the EC member of SFO. He is the Scientific Secretary of the Oncology Club, Bangladesh. He is the only Oncologist in the country having a post-graduate degree in respiratory medicine and Oncology. His field of interest is Lung Cancer, Urological Malignancies, Gynecological Cancer and Breast Cancer. He is involved in treating patients with precision Radiation therapy techniques like SBRT and treated the first HCC and RCC patient with Stereotactic Body Radiation Therapy (SBRT) technique in Bangladesh.

Dr. Krishna Kumar has Fifteen years of work experience in Medical Oncology, 12 years as a Senior Consultant and Head of the Department of Medical Oncology at Meenakshi Mission Hospital & Research Centre, Madurai since 2010.

 Dr. Kumar is Professor, Medical Oncology at Tata Memorial Hospital and has more than two decades of experience. He has published over a hundred research and review articles/papers in journals of national and international repute.He has undertaken over 80 projects as Principal Ivestigator and Co-Investigator.He is a member of many international and national scientific societies and associations and has delivered talks in several conferences.

Professor Marwan Ghosn acquired his medical degree and his post-graduate expertise in Hematology Oncology from Faculty of Medicine, Saint Joseph University in Beirut- Lebanon; as well as from the University of Paris XI, Le Kremlin Bicêtre and Institut Gustave Roussy Cancer Center in Villejuif- France. He served as the Director of the Hematology Oncology Post-Graduate Program for more than twenty years and the Chairman of the Hematology Oncology Department at Faculty of Medicine, Saint Joseph University in Beirut- Lebanon. He acquired a Master in Hospital and Health Management from The Higher School of Business, ESA in Beirut and a Master in the Quality Management of Units for Care Production (MUPS) from the University of Paris VII, Denis Diderot in France. He is currently the Director of the Cancer Center and the Head of Hematology Oncology Division at Clemenceau Medical Center affiliated with Johns Hopkins International in Beirut- Lebanon, and Consultant Medical Oncology at Clemenceau Medical Center in Dubai- United Arab Emirates. Professor Marwan Ghosn has also served for more than 12 years, as Chairman of the Hematology Oncology Department at Hôtel-Dieu de France University Hospital in Beirut, where he is actually continuing his clinical, medical, academic, and research activities. He served as President of the Lebanese Society of Medical Oncology (LSMO) and was member of the Board of the Lebanese Cancer Society (LCS) for many years. He is an active member of several national and international scientific organizations and societies; including the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), the European Society of Medical Oncology (ESMO), the American Society of Hematology (ASH), the European Hematology Association (EHA), the International Society of Geriatric Oncology (SIOG), and the Arab Medical Association Against Cancer (AMAAC). He is author and co-author of more than 200 peer-reviewed articles. He also published and gave an extensive number of communications, posters, and abstracts at regional and international meetings; as well as several chapters in books in the field of Medical Oncology and Health Care Management. He is the Editor in Chief of the “Pan Arab Journal of Oncology” (PAJO) edited by the Arab Medical Association Against Cancer (AMAAC) and has previously served as Editor in Chief of the “Cancer Letter” edited by the Lebanese Cancer Society. Professor Ghosn has special interests in multiple areas including leadership in conducting research and clinical trials in multiple solid tumors. He has an expertise in breast cancer, urologic cancers, gastrointestinal tumors, geriatric oncology domain as well as in Patients’ Safety and Quality in Healthcare.

Dr. Mostafa Aziz Sumon completed his MBBS degree from Mymensingh Medical College, Under the University of Dhaka in 2001. Then he completed his Post Graduation MCPS in Radiotherapy MD in Radiation Oncology in 2012. Currently, he working as a Head of the Department, Oncology, Kurmitola General Hospital, Dhaka. He joined as a Consultant, Radiation Oncology in Labaid Cancer Hospital & Super Speciality Center from 2021. He is also worked in Japan Bangladesh Friendship Hospital consultant of Oncology. He was declared as ESMO- Leader of Asia (LGP Progroam-2019). He was awarded “ABMF GOLD MEDAL” for best paper in 11th SAARC Federation of Oncology Cancer Congress 2016. He is trained in Bologna University, Italy, and National University Hospital Singapore. He is an IAEA fellow and the Country Coordinator of a multinational, multicenter trial on “Evidence-based on lab medicine in Oncological practice” under Yamaguchi University, Japan. (More details visit: www.drsumon.net)

” Dr. Navneet Singh is a thoracic medical oncologist, tenured professor of pulmonology and faculty-incharge of the Lung Cancer Clinic at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. His primary area of clinical expertise & research is thoracic oncology especially targeted therapies and immunotherapy for treatment of non-small cell lung cancer (NSCLC). He is the coordinator & convener for PGIMER’s multidisciplinary thoracic oncology group that received the Lung Cancer Care Team Award (Overall Winner) of the International Association for Study of Lung Cancer (IASLC) at its 20th World Conference on Lung Cancer (WCLC) in Barcelona, Spain [2019].”

Dr. Nikhil S Ghadyalpatil is a Senior Consultant Medical Oncologist & Hemato-Oncologist at Yashoda Hospitals, Somajiguda, with over 17 years of experience. He is an expert in Oncology/Cancer treatment, as well as clinical research and medical education, and has treated over 5000 national and international cancer patients.

Dr. Nitesh Rohatgi is Senior Director Medical Oncology at Fortis Memorial Research Institute, Gurugram, he was previously working at the prestigious London Oncology Clinic (Leaders in Oncology care), Harley Street, London. He is a fellow of the Royal College of Physicians (U.K Edinburgh) as well as Royal Society of medicine. Besides being a key opinion leader in Oncology in India he has been a PI on clinical trials (presently for BIRAC -Oncology) and has much publication to his name. He was trained in medical oncology, palliative medicine and teenage young adult’s cancers in United Kingdom, completing his CCT in 2009.

” Areas of interest in Oncoimaging: Head and Neck Thorax Musculoskeletal Awards Awarded “Certificate of Merit” for electronic poster titled “Posttreatment imaging in head and neck cancers: To worry or not to worry?” at the European Congress of Radiology (ECR) 2023 conference held in Vienna from 1st to 5th March 2023. Professional affiliations: 1. Life Member of the Indian Radiological & Imaging Association (IRIA). 2. Life Member of Indian Society of Head and Neck Radiology (ISHNR) 3. Corresponding Member of European Society of Radiology (ESR). 4. Life member of Society of Chest Imaging and Interventions (SCII) 5. Life Membaer of Indian Association of Cardiac Imaging (IACI) 6. Associate Member of Musculoskeletal Society of India. (MSS) 7. Life member of Indian Musculo Skeletal Oncology Society (IMSOS).

Prof Omshree Shetty as a scientific officer at Molecular Pathology , Department of Pathology, Tata Memorial Hospital for more than a decade (since 2012). As a Scientific officer working in the Molecular Diagnostics laboratory, my vision includes providing accurate, reliable diagnosis with consistent quality ensuring quality patient management. The laboratory is primarily involved in solid tumor molecular diagnostics ranging from single gene sequencing, Next Generation Sequencing, Gene expression profiling,FISH,DDPCR , Real time PCR. As one of the leading molecular diagnostic centers for solid tumors in the country, I have initiated a quality assurance program for molecular Diagnostics Molecular Pathology Quality Assurance Program [MPQAP].We provide quality assurance program in solid tumor molecular diagnostics. I have been involved in various collaborative studies with academic institution like Indian Institute of Technology (IIT-B) [Department of Biotechnology DBT, Department of Health and Research (DHR, INDIA)], I am also involved in a pivotal project involving developing Advanced Molecular Diagnostics centre across India in the project entitled DHR-ICMR Advanced Molecular Diagnostics Services (DiAMONDS). She has led the translational research team to carry out the functional genomics and transcriptomic based discoveries successively and presented those at international and national meetings. “

Dr Prabhat is Additional Professor, in the Department of Medical Oncology, at All India Institute of Medical Sciences, New Delhi. His Major scientific fields of interest are Lung Cancer treatment, Molecular profiling and targeted therapies in NSCLC, Cancer immunology and Metronomic therapies and drug repositioning.

” Dr. Prashant Kumar brings along with him vast expertise & accomplishments in the field of Cancer Biology and has done extensive research to enhance the translational merits of cancer research. He worked in several path-breaking research initiatives that includes establishing a novel mouse model of malignant breast cancers, optimization of a culture method to assess CTCs, implementation of cutting-edge technologies in genomics, proteomics to investigate biomarkers and therapeutic targets to accelerated discovery in the advancement towards cancer vaccines, precision medicine, molecular diagnostics. Dr. Kumar received his Ph.D. in 2009 from the Max Planck Institute for Infection Biology, Berlin, Germany. Following this, he did his postdoctoral work at the Department of Cancer Biology, UMASS, Worcester, USA. To further advance his research stint, he joined Prof. Jean-Paul Thiery, a world-renowned authority in the area of EMT at IMCB, A-STAR Singapore. Currently he is the Chief Scientific Officer (CSO) of Karkinos Healthcare. “

 Dr. Rajeeb Kumar Deo is Oncologist in Kathmandu. Dr. Rajeeb Kumar Deo is affiliated with medical facilities such as Om Hospital & Research Centre Pvt. Ltd., Nepalese Army Institute of Health Sciences and many more. Dr. Rajeeb Kumar Deo graduated from B.P. Koirala Institute of Health Sciences, Nepal, Armed Forces Medical College, Pune and many more.

In 2016, Dr. Ramaswamy Govindan was appointed the Anheuser-Busch Endowed Chair in Medical Oncology at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. He also serves as a professor of medicine and as the director of the Section of Medical Oncology. Govindan is part of a multidisciplinary team at Siteman Cancer Center that specializes in lung cancer and pleural mesothelioma treatment. He works closely with surgeons Dr. Alexander Patterson and Dr. Benjamin Kozower, who also specialize in lung diseases, along with a team that includes pulmonologists and radiologists. Govindan was the principal investigator for a phase II clinical trial studying mesothelioma and the drug Iressa (gefitinib). He is currently conducting several clinical trials involving lung cancer. He also is known for his patient-centric care in the clinic and his bedside manner. “When you are told you have cancer, it is a big, life-changing event,” Govindan said. “We do our best to reassure our patients of the possibilities and the hope that is there. At the same time, we have to be very honest and candid with our patients.” Govindan is known for his innovative research, particularly in genomics, that is being used to develop better lung cancer therapies and significantly improve patient outcomes. He is co-chair of The Cancer Genome Atlas project, a nationwide effort to personalize cancer care through identifying genetic mutations. He earned his medical degree from the University of Madras in India and completed his fellowship in hematology and oncology at the Washington University School of Medicine. Govindan did a residency in internal medicine at the Michael Reese Hospital in Chicago before joining the Washington University faculty in 1998.

Prof. RaviKrishna Madala is qualified in MD Radiation oncology. He is working as DM Medical Oncology atTata memorial hospital Mumbai,India. Previously he worked as a Asst Prof in Tata memorial centre, India.

Dr Ross Soo is a Senior Consultant at the Department of Haematology-Oncology, NCIS, and an Adjunct Principal Investigator, Cancer Science Institute of Singapore, NUS. He received his medical degree from Monash University, underwent specialist training in Melbourne and Sydney and subsequently became a Fellow of the Royal Australasian College of Physicians and the Academy of Medicine, Singapore. He specializes in lung cancer, head and neck cancer and leads the Lung tumour Group at the National University Cancer Institute, Singapore. His professional affiliations include memberships of the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, and the Singapore Society of Oncology. He sits on various committees including National Healthcare Group Domain-Specific Ethics Review Board, Ministry of Health Drug Advisory Committee, Medical Oncology Specialist Training Committee, and Communications Committee, International Association for the Study of Lung Cancer. His research interests are in lung cancer, nasopharyngeal cancer, and gastrointestinal cancers and have received grants for research work in these areas. He has been invited to speak and present his research findings at many international meetings and has published more than 80 papers in journals including Cell, Nature Medicine, Science Translational Medicine, Journal of Clinical Oncology, Lancet Oncology, and Cancer Research.

Professor Sabita is a Thoracic services professor at Department of Surgical Oncology,Tata Memorial Hospital, Parel

 Dr. Sai Vivek is an experienced oncologist currently working as Consultant Medical and Hemato Oncologist at Aster Hospitals, Bangalore. With close to 6 years of experience in the field of oncology, Dr .Vivek has a keen interest in solid organ and blood cancers in adults and children, precision oncology immunotherapy, preventive oncology and integrative oncology. He completed his MBBS in surgery from Sri Devaraj Urs Medical College, Bangalore (2012) and MD in internal medicine from JSS Medical College, Mysore, Karnataka (2015). He also holds a fellowship in medical oncology (DM) from Vydehi institute of Medical sciences, Bangalore (2019) along with a certification in ECMO. Prior to joining Aster Hospitals, Dr. Vivek was working as a consultant at Sri Shankara Cancer Hospital and Research Centre, Bangalore.

Professor Popat has both a private and an NHS practice at The Royal Marsden. He is a Consultant Medical Oncologist at The Royal Marsden, Professor of Thoracic Oncology at the Institute of Cancer Research, and is an internationally recognized expert in the treatment of lung cancer, mesothelioma and cancers of the thymus (thymoma and thymic carcinoma). Professor Popat qualified in 1994 from Guy’s and St Thomas’ Hospitals with triple distinction and was awarded a PhD in Molecular Genetics in 2002, undertaking a postdoctoral Clinician Scientist Fellowship and a HEFCE Clinical Senior Lectureship thereafter. He has been awarded nationally and internationally competitive prizes for his research, in addition to four research fellowships. His research interests include the complexities of genetic profiling in cancer, as well as developing novel drug treatments through clinical trials. He also holds several national and international roles. Nationally, Professor Popat Chairs the British Thoracic Oncology Group (BTOG) Steering Committee, is Co-Director for the NIHR London South Clinical Research Network Cancer Division, the NIHR Lung Cancer National Specialty Lead and is past Sub-group Chair of the NCRI Lung Group. Internationally, he sits on the Foundation Council of the European Thoracic Oncology Platform (ETOP) and is active in the European Society of Medical Oncology (ESMO) where he has co-authored European Clinical Practice Guidelines for Small Cell Lung Cancer, Non-Small Cell Lung Cancer, and Mesothelioma. His research collaborations with industry have led to licensing of several drugs globally, leading to implementation in International treatment guidelines and NHS funding approvals. Professor Popat is often an invited Clinical Expert to the National Institute for Health and Care Excellence (NICE) and sits on several committees overseeing the safety and governance for ongoing UK and international clinical trials. Sanjay is a strong advocate for patient education and support and is clinical advisor to several patient-facing cancer charities.

A highly skilled Radiologist, studied and trained in one of the largest and premier Medical Institutions of South Asia ( Tata Memorial Centre, Bombay) practising all modalities of Radiology with equal enthusiasm and expertise. Extensive work experience in sonography including fetal morphology scan and Doppler scans. Expertise in Cross sectional CT and MRI imaging with special interest in MSK imaging, neurospinal imaging, coronary CT imaging, head and neck imaging and breast imaging. Specially trained in onco-imaging, women’s imaging and image guided interventions. Has been Teaching faculty in Medical College in India. Published in many indexed journals and delivered lectures in many National and International conferences. Participated in many National and International clinical trials

Dr. Sewanti Limaye is the Director of Medical & Precision Oncology, at Sir H. N. Reliance Foundation Hospital Dr. Limaye, established Precision Oncology clinic – led for the first time by a medical oncologist in the country. She also took Oncology Clinical and Translational research at the center to new heights. Dr. Limaye has earlier worked at Columbia University Medical Center-New York Presbyterian Hospital, where she worked in Medical Oncology and was Assistant Professor of Medicine and specialized in Thoracic, Head & Neck, GI Oncology and Early Drug Development. Prior to joining Columbia University Dr. Limaye worked as an Attending in Medical Oncology at the Dana Farber Cancer Institute/Brigham and Women’s Hospital and at the Phase I – Early Drug Development Center – Harvard Medical School in Boston, USA. She specializes in the treatment of all solid tumors including Breast, Lung, Head and Neck, GI, GU and Gyn Cancers. Dr. Limaye received her medical degree with honors from Jawahar Lal Nehru Medical College, Bhagalpur and did her residency in Internal Medicine from New York University and did her fellowship in Hematology and Medical Oncology from Albert Einstein University, New York. She also did a Masters in Patient Oriented Research (Cancer Genomics and Biostatistics) from Mailman School of Public Health, Columbia University. Dr. Limaye has been involved in research with leaders at Memorial Sloan Kettering Cancer Center, Dana Farber Cancer Institute, Columbia University Medical Center and National Cancer Institute, USA. She serves on Tata Memorial Hospital Ethics board. She has also co- founded Iylon Precision Oncology with Dr. Sendurai Mani from MDACC, an international precision effort with global leaders and IMPACT India International initiative at the national level. She has led several national and international trials and has been a part of Data Safety Monitoring Boards. Dr. Limaye was awarded with the John-Flynn Young investigator Award for excellence in clinical research, the Rose and Jack Horowitz Award for excellence in patient care and Medical Oncology Research Excellence Award-ASCO 2008 for excellence in clinical research. She was nominated to serve as the National Chair of the Sub-protocol Arm B of the landmark NCI-MATCH Trial. Dr. Limaye is committed to the development of Precision protocols in Cancer Care and also in the development of novel therapeutics in solid tumors. At Sir H. N. Reliance Foundation Hospital, Dr. Limaye envisions to bring excellence in Cancer Care, Precision Oncology and Cancer Research.

 Shaheenah Dawood is a consultant medical oncologist and professor in clinical oncology in the United Arab Emirates. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. She also serves as president of the Excellence in Oncology Care summit that is held annually in Dubai and is co-president of the Asia-Pacific Breast Cancer Summit (APBCS) and Asia-Pacific Gastroenterology Cancer Summit (APGCS). She has also recently launched the International BRCA Forum and Young Women’s Forum.

Assistant professor in Radiation Oncology at Tata Memorial Centre, Mumbai primarily treating Head and Neck cancers. I trained at the West German Proton Therapy Centre (WPE), Essen, Germany in 2022 in proton therapy for head and neck, and skull base malignancies. Other areas of interest/ research include health economics, artificial intelligence, and global oncology.

Dr Simit Sapkota is leading Oncologist of country and is vocal advocate of “Quality treatment to all”. He is almuni of prestigious Post Gradiuate Institute (PGI -Chandigarh) He is involved in management of all kind of malignancies and has special interest on GI-HPB cancers Gyanecological cancers, Lung cancers and Brain tumors. He is passionate about interstitial brachytherapy for organ preservation and immunotherapy and targeted therapy in in gastro-intestinal/ pancreatic and hepato-biliary cancers. His research interest is in Human Papilloma Virus Infection in Head and Neck cancer pateints.

Dr Subhas is considered one of the leading Oncologist in country. Graduate from prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, he is credited for starting advanced radiotherapy techniques like IMRT and VMAT in country.He has done fellowship in Head & Neck IMRT with Prof. Vincent Gregoire. He has special interest in Head & Neck,Lung Cancer, Breast cancers and Prostate cancer. He is passionate about Interstitial Brachytherapy, Magna-field radiotherapy (Total Body Irradiation, Total Skin Electron Therapy) and molecular oncology. His research interests are Cancer Epidemiology and Quality of Life of cancer patients. He has authored chapters in Radiation Oncology and Neuro-oncology books.

Prof. Dr. Syed Md Akram Hussain, MBBS, FCPS, FRCP, FACP is a physician of Oncology is now working in Square Hospitals Ltd. as head of Square Cancer Centre. with his prominent reputation in education, skill and adequate experiences in working in various capacities of hospitals at home and abroad. He has 25 years of practical experience and expertise in the field of Clinical Oncology. Prof. Akram has a very rich track record of working in different organizations in his career. Previously he performed as Founder Chair of Oncology Department of Bangabandhu Sheikh Mujib Medical University, Founder Senior Consultant of Ahsania Mission Cancer Hospital,Dhaka and North East Cancer Hospital,Sylhet. and Chief Consultant, Clinical Oncologist in Lab Aid Specialized Hospital, Dhaka. He is now performing as Co Chairman of Faculty of Clinical Oncology of Bangladesh College of Physicians and Surgeons (BCPS). He has more than 150 publications published in reputed journal, currently he is a editorial board member of Journal of Bangladesh College of Physicians and Surgeons. He is a member of many national and international organizations like Life member of Oncology Club, Bangladesh, ESMO and ASCO. He is especially interested in Lung, Breast, GI and Gynecological Cancers.

” Dr T Raja with 20 years of experience as a Medical Oncologist, Dr. T Raja has a proven track record of dealing with cancer patients. His expertise and insights in cancer treatment makes him one of the top oncologists in the country. Along with a successful career as an Oncologist, Dr. Raja also actively participates in international conferences related to Oncology. He has published numerous papers on oncology in internationally recognized journals. Dr. Raja continues to be a regular follower the latest advancements in the field of medical oncology.”

Dr UllasBatra obtained his DM in Medical Oncology from the prestigious Kidwai Memorial Institute of Oncology. He has gained widespread experience in the management of various malignancies like Lung cancer, breast cancer, GI Cancers and hematological malignancies etc. He has also done perceptorship in various International Institutes like MD Anderson Cancer Centre, USA, Royal Adelaide Hospital, Australia. He has participated as a Principal investigator and co Investigator in various phase II and III clinical trials. He has numerous publications to his credit in reputed Journals and Research gate, an online repository of scientific articles has listed 49 of them. He has actively participated in organizing various seminars, CMEs, conferences throughout country. He is also a Thesis guide to DNB residents. At present, he is working as Senior Consultant and Chief of Thoracic Medical Oncology at Rajiv Gandhi cancer Institute and Research Centre.

Dr. Vanita Noronha is one of the most esteemed & renowned Geriatric Oncology in Mumbai with an overall experience of 25 years in this field. She is currently practicing at Tata Memorial Hospital, Parel, Mumbai. Dr. Vanita Noronha is constantly working on new treatments for significant improvement in survival rates by providing access to affordable and effective treatment plans.

Dr. Vidya H Veldore, Principal Scientist – Oncology working currently at 4baseCare.

 Dr. Vijay Patil is a well-experienced Medical Oncologist with 16 years of experience currently working at P. D. Hinduja Hospital, Mumbai, and has managed to achieve a broad spectrum of cancer conditions. He is considered to be the leading pioneer in the field of medical oncology who has revolutionized cancer treatments with his advanced research and studies.